934 related articles for article (PubMed ID: 35403707)
1. Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes.
Chen F; Wen W; Long J; Shu X; Yang Y; Shu XO; Zheng W
Int J Cancer; 2022 Aug; 151(3):372-380. PubMed ID: 35403707
[TBL] [Abstract][Full Text] [Related]
2. Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study.
Dimou NL; Papadimitriou N; Gill D; Christakoudi S; Murphy N; Gunter MJ; Travis RC; Key TJ; Fortner RT; Haycock PC; Lewis SJ; Muir K; Martin RM; Tsilidis KK
Int J Epidemiol; 2019 Jun; 48(3):807-816. PubMed ID: 31143958
[TBL] [Abstract][Full Text] [Related]
3. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis.
Hazelwood E; Sanderson E; Tan VY; Ruth KS; Frayling TM; Dimou N; Gunter MJ; Dossus L; Newton C; Ryan N; Pournaras DJ; O'Mara TA; Davey Smith G; Martin RM; Yarmolinsky J
BMC Med; 2022 Apr; 20(1):125. PubMed ID: 35436960
[TBL] [Abstract][Full Text] [Related]
4. Circulating sex hormone-binding globulin levels and ischemic stroke risk: a Mendelian randomization study.
Zeng Y; Cao S; Yang H
Postgrad Med J; 2023 Nov; 99(1178):1272-1279. PubMed ID: 37742091
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women.
Murphy N; Knuppel A; Papadimitriou N; Martin RM; Tsilidis KK; Smith-Byrne K; Fensom G; Perez-Cornago A; Travis RC; Key TJ; Gunter MJ
Ann Oncol; 2020 May; 31(5):641-649. PubMed ID: 32169310
[TBL] [Abstract][Full Text] [Related]
6. Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: a Mendelian randomisation analysis.
Shu X; Zhou Q; Sun X; Flesaker M; Guo X; Long J; Robson ME; Shu XO; Zheng W; Bernstein JL
Br J Cancer; 2022 Nov; 127(8):1507-1514. PubMed ID: 35882941
[TBL] [Abstract][Full Text] [Related]
7. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
8. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.
Shu X; Wu L; Khankari NK; Shu XO; Wang TJ; Michailidou K; Bolla MK; Wang Q; Dennis J; Milne RL; Schmidt MK; Pharoah PDP; Andrulis IL; Hunter DJ; Simard J; Easton DF; Zheng W;
Int J Epidemiol; 2019 Jun; 48(3):795-806. PubMed ID: 30277539
[TBL] [Abstract][Full Text] [Related]
9. Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study.
Fu Y; Xu F; Jiang L; Miao Z; Liang X; Yang J; Larsson SC; Zheng JS
BMC Med; 2021 Jul; 19(1):171. PubMed ID: 34325683
[TBL] [Abstract][Full Text] [Related]
10. Identifying and ranking causal biochemical biomarkers for breast cancer: a Mendelian randomisation study.
Tang SN; Zuber V; Tsilidis KK
BMC Med; 2022 Nov; 20(1):457. PubMed ID: 36424572
[TBL] [Abstract][Full Text] [Related]
11. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study.
Johnson KE; Siewert KM; Klarin D; Damrauer SM; ; Chang KM; Tsao PS; Assimes TL; Maxwell KN; Voight BF
PLoS Med; 2020 Sep; 17(9):e1003302. PubMed ID: 32915777
[TBL] [Abstract][Full Text] [Related]
12. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.
Beeghly-Fadiel A; Khankari NK; Delahanty RJ; Shu XO; Lu Y; Schmidt MK; Bolla MK; Michailidou K; Wang Q; Dennis J; Yannoukakos D; Dunning AM; Pharoah PDP; Chenevix-Trench G; Milne RL; Hunter DJ; Per H; Kraft P; Simard J; Easton DF; Zheng W
Int J Epidemiol; 2020 Aug; 49(4):1117-1131. PubMed ID: 31872213
[TBL] [Abstract][Full Text] [Related]
13. Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study.
Richmond RC; Anderson EL; Dashti HS; Jones SE; Lane JM; Strand LB; Brumpton B; Rutter MK; Wood AR; Straif K; Relton CL; Munafò M; Frayling TM; Martin RM; Saxena R; Weedon MN; Lawlor DA; Smith GD
BMJ; 2019 Jun; 365():l2327. PubMed ID: 31243001
[TBL] [Abstract][Full Text] [Related]
14. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study.
Tan H; Wang S; Huang F; Tong Z
Front Endocrinol (Lausanne); 2023; 14():1138149. PubMed ID: 37288296
[TBL] [Abstract][Full Text] [Related]
15. Relationship between oily fish intake and breast cancer based on estrogen receptor status: a Mendelian randomization study.
Wu S; Ma X; Zhang X; Shi C; Cao M; Yang C; Qi Y; Liu Y
Breast Cancer Res Treat; 2024 Jan; 203(1):145-152. PubMed ID: 37787818
[TBL] [Abstract][Full Text] [Related]
16. Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: A Mendelian randomization study.
Papadimitriou N; Dimou N; Gill D; Tzoulaki I; Murphy N; Riboli E; Lewis SJ; Martin RM; Gunter MJ; Tsilidis KK
Int J Cancer; 2021 Feb; 148(3):646-653. PubMed ID: 32761610
[TBL] [Abstract][Full Text] [Related]
17. Major depression disorder may causally associate with the increased breast cancer risk: Evidence from two-sample mendelian randomization analyses.
Ren Q; Luo F; Ge S; Chen P
Cancer Med; 2023 Jan; 12(2):1984-1996. PubMed ID: 35852181
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cytokines and two subtypes of breast cancer: A two-sample mendelian randomization study.
Zhou H; Cai Z; Yang Q; Yang X; Chen J; Huang T
PLoS One; 2023; 18(11):e0293230. PubMed ID: 37910571
[TBL] [Abstract][Full Text] [Related]
20. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study.
Hayes BL; Robinson T; Kar S; Ruth KS; Tsilidis KK; Frayling T; Murray A; Martin RM; Lawlor DA; Richmond RC
PLoS Genet; 2022 Jan; 18(1):e1009887. PubMed ID: 35061662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
